207 related articles for article (PubMed ID: 15640130)
1. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
3. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
Popov D
Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
Cho H
Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
[TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
7. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.
Zabolotny JM; Kim YB; Welsh LA; Kershaw EE; Neel BG; Kahn BB
J Biol Chem; 2008 May; 283(21):14230-41. PubMed ID: 18281274
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
Panzhinskiy E; Ren J; Nair S
Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
[TBL] [Abstract][Full Text] [Related]
9. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
10. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
Zhang ZY; Lee SY
Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
[TBL] [Abstract][Full Text] [Related]
11. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
Goldstein BJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
[TBL] [Abstract][Full Text] [Related]
13. Bioguided isolation of (9Z)-octadec-9-enoic acid from Phellodendron amurense Rupr. and identification of fatty acids as PTP1B inhibitors.
Steinmann D; Baumgartner RR; Heiss EH; Bartenstein S; Atanasov AG; Dirsch VM; Ganzera M; Stuppner H
Planta Med; 2012 Feb; 78(3):219-24. PubMed ID: 22124950
[TBL] [Abstract][Full Text] [Related]
14. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B.
Xu JQ; Shen Q; Li J; Hu LH
Bioorg Med Chem; 2010 Jun; 18(11):3934-9. PubMed ID: 20472439
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
Delibegović M; Dall'Angelo S; Dekeryte R
Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
[TBL] [Abstract][Full Text] [Related]
16. Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone.
Ali MI; Ketsawatsomkron P; Belin de Chantemele EJ; Mintz JD; Muta K; Salet C; Black SM; Tremblay ML; Fulton DJ; Marrero MB; Stepp DW
Circ Res; 2009 Nov; 105(10):1013-22. PubMed ID: 19797171
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.
Ma Y; Sun SX; Cheng XC; Wang SQ; Dong WL; Wang RL; Xu WR
Chem Biol Drug Des; 2013 Nov; 82(5):595-602. PubMed ID: 23848232
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
19. Protein-tyrosine phosphatase 1B as a potential drug target for obesity.
Dadke S; Chernoff J
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461
[TBL] [Abstract][Full Text] [Related]
20. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
